NCT03561610

Brief Summary

This study evaluates if a novel form of oral nutritional Supplement application in the form of gumdrops may serve as an alternative to common sip Feeds in cancer patients with high risk for malnutrition. Within this context the Impact of these two different supplements on General condition, Quality of life, muscle function, Body composition, Appetite and Nutrition Status are investigated. Patients are randomly allocated either to a study group with oral Supplementation in the form of sip feed or to a study Group receiving gumdrops for 4 weeks. After a washout period of 5-7 days study Groups are switched for another 4 week Intervention period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 4, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 19, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

June 19, 2018

Status Verified

June 1, 2018

Enrollment Period

1 year

First QC Date

June 4, 2018

Last Update Submit

June 18, 2018

Conditions

Keywords

cancer cachexiamalnutritionnutritional supplementsip feednutritional risk

Outcome Measures

Primary Outcomes (2)

  • Compliance

    compliance of nutritional supplement intake assessed by Medication Adherence Report Scale (MARS-D); Total score ranges from 0-10 with a higher score indicating better adherence

    4 weeks

  • Tolerance of the form of oral supplementation

    assessment of hedonic and sensoric estimation of oral supplements by questionnaire

    4 weeks

Secondary Outcomes (9)

  • Body weight

    4 weeks

  • Body composition

    4 weeks

  • Physical function - Isometric muscle strength

    4 weeks

  • Physical function - Lower limb strength

    4 weeks

  • Physical function - Endurance

    4 weeks

  • +4 more secondary outcomes

Study Arms (2)

Study group 1

ACTIVE COMPARATOR

normal Nutrition + sip feed (covers individual energy and nutrient demands)

Dietary Supplement: sip feed

Study group 2

EXPERIMENTAL

normal Nutrition + gumdrops (covers individual energy and nutrient demands)

Dietary Supplement: gumdrops

Interventions

sip feedDIETARY_SUPPLEMENT

normal oral Nutrition + sip feed (Fresubin2.0®; covers individual energy and nutrient demands; high in protein)

Study group 1
gumdropsDIETARY_SUPPLEMENT

normal oral Nutrition + gumdrops (Nutrimed®; covers individual energy and nutrient demands; high in protein)

Study group 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients with solid and hematological malignancies
  • BMI \< 20 kg/m² and/or NRS-2002 Score ≥ 3

You may not qualify if:

  • pregnant or nursing women
  • persons with psychiatric disorders with doubts about legal and cognitive capacity
  • participation in nutritional Intervention Trials within the last 4 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg

Erlangen, 91052, Germany

RECRUITING

MeSH Terms

Conditions

NeoplasmsMalnutritionCachexia

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesWeight LossBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsThinness

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2018

First Posted

June 19, 2018

Study Start

May 1, 2018

Primary Completion

May 1, 2019

Study Completion

May 1, 2019

Last Updated

June 19, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations